CA-REZZ NORISC ANTIBACTERIAL SKIN CARE- benzethonium chloride cream

CA-REZZ NORISC by

Drug Labeling and Warnings

CA-REZZ NORISC by is a Otc medication manufactured, distributed, or labeled by FNC MEDICAL CORPORATION. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

ACTIVE INGREDIENT

BENZETHONIUM CHLORIDE 0.2%

PURPOSE

ANTIBACTERIAL

USES

CA-REZZ NORSIC CREAM IS A NON-GREASY ANTIBACTERIAL CREAM SPECIALLY FORMULATED TO SOOTHE SKIN TISSUE. IT IS IDEAL FOR USE ON IRRITATED SKIN. IT REDUCES COMMON GERMS THAT CAN CAUSE PAINFUL RASHES.

WARNINGS

FOR EXTERNAL USE ONLY. IF RASH OR IRRITATION DEVELOP, DISCONTINUE USE. CONSULT A PHYSICIAN IF IRRITATION PERSISTS.

KEEP OUT OF REACH OF CHILDREN

KEEP OUT OF REACH OF CHILDREN.

DIRECTIONS

1. APPLY A SMALL AMOUNT OF CREAM TO SKIN AND RUB GENTLY.
2. USE AS A MASSAGE CREAM FOR IMMOBILE PATIENTS TO IMPROVE CIRCULATION.

OTHER INFORMATION

CA-REZZ NORSIC CREAM IS ENRICHED WITH VITAMINS A, D & E, ALOE VERA AND ALLANTOIN.

INACTIVE INGREDIENTS

DEIONIZED WATER, MINERAL OIL, ALOE VERA EXTRACT, PROPYLENE GLYCOL, STEARIC ACID, GLYCERYL STEARATE AND PEG 100 STEARATE, SAFFLOWER OIL, CETYL ALCOHOL, TRIETHANOLAMINE, SORBITAN, ISOSTEARATE, DIMETHICONE, ALLANTOIN, TOCOPHERYL ACETATE, RETINYL PALMITATE, ERGOCALCIFEROL, PHENOXYETHANOL, ETHYLHEXYLGLYCERIN, FRAGRANCE.

QUESTIONS/COMMENTS?

PLEASE CALL (800) 440-2888

PRINCIPAL DISPLAY PANEL

INGREDIENTS AND APPEARANCE

CA-REZZ NORISC  ANTIBACTERIAL SKIN CARE
benzethonium chloride cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 60762-112
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
BENZETHONIUM CHLORIDE (UNII: PH41D05744) (BENZETHONIUM - UNII:1VU15B70BP)	BENZETHONIUM CHLORIDE	0.2 g  in 100 g

Inactive Ingredients
Ingredient Name	Strength
WATER (UNII: 059QF0KO0R)
MINERAL OIL (UNII: T5L8T28FGP)
ALOE VERA WHOLE (UNII: KIZ4X2EHYX)
PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
STEARIC ACID (UNII: 4ELV7Z65AP)
GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
PEG-100 STEARATE (UNII: YD01N1999R)
SAFFLOWER OIL (UNII: 65UEH262IS)
CETYL ALCOHOL (UNII: 936JST6JCN)
TROLAMINE (UNII: 9O3K93S3TK)
SORBITAN ISOSTEARATE (UNII: 01S2G2C1E4)
DIMETHICONE (UNII: 92RU3N3Y1O)
ALLANTOIN (UNII: 344S277G0Z)
.ALPHA.-TOCOPHEROL ACETATE (UNII: 9E8X80D2L0)
VITAMIN A PALMITATE (UNII: 1D1K0N0VVC)
ERGOCALCIFEROL (UNII: VS041H42XC)
PHENOXYETHANOL (UNII: HIE492ZZ3T)
ETHYLHEXYLGLYCERIN (UNII: 147D247K3P)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 60762-112-09	275 g in 1 TUBE; Type 0: Not a Combination Product	02/05/2018
2	NDC: 60762-112-04	120 g in 1 TUBE; Type 0: Not a Combination Product	02/05/2018

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph not final	part333A	02/05/2018

Labeler - FNC MEDICAL CORPORATION (849207519)

Registrant - FNC MEDICAL CORPORATION (849207519)

Establishment
Name	Address	ID/FEI	Business Operations
FNC MEDICAL CORPORATION		849207519	label(60762-112) , manufacture(60762-112)